Maebashi

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic myeloid leukaemia1 trial
• Diabetic eye disease1 trial
• Multiple sclerosis1 trial
• Neuroendocrine tumours1 trial

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  Specified Drug-use Surveillance of Fabhalta Capsules

  NCT06606314· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

  NCT05526729· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Surveillance of Scemblix Tablets

  NCT05421091· Novartis Pharmaceuticals· Source

• Completed

  LUTATHERA Injection General Use Result Survey

  NCT05844332· Novartis Pharmaceuticals· Source

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Novartis Pharmaceuticals· Source